Netherlands· NL-a62b4bb4414a

Mifegyne 200 mg, tabletten

A mifepristone product containing mifepriston, registered in Netherlands by Euro Registratie Collectief B.V.. The same ATC class is registered in 14 of our 19 countries.

ATC G03XB01

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about mifepristonAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Mifepristone is registered in 14 of 19 countries.

Countries holding a registration under ATC G03XB01 (mifepristone), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
8 of them publish a price we can compare per daily dose

Search mifepristone products by name

Mifepristone · ATC G03XB01

14 / 19 countries

Belgiumprice
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Netherlands
Norwayprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of mifepristone costs, country by country.

Normalised to the WHO defined daily dose (0.2 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Mifepristone · price per daily dose (0.2 g)

USD · FX 28 Sept 2026

CH Switzerland$53.60

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: MIFEPRISTON
Manufacturer: Euro Registratie Collectief B.V.
Country: Netherlands (NL)
ATC code: G03XB01
ATC class: Mifepristone
Defined daily dose: 0.2 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
128040//24206

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

378 interactions on record for mifepristone.

Graded by severity as the source publishes them — 209 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check mifepristone against other medicines How interaction checks work

Mifepristone · interactions on record

378 records

209 severe
161 moderate
8 minor

Most severe, free to view

PapaverineA03AD01severe
CisaprideA03FA02severe
OndansetronA04AA01severe
GranisetronA04AA02severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Mifepristone in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All mifepristone products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

Austria · Mifegyne
Belgium · Mifegyne
Bulgaria · Мифегин
Cyprus · Mifegyne
Czechia · Mifegyne
Germany · Mifegyne
Denmark · Mifegyne
Estonia · Mifegyne
Spain · Mifegyne
Finland · Mifegyne
France · Mifegyne, Miffee
United Kingdom (Northern Ireland) · Mifegyne, Mifepristone Linepharma
Greece · Mifegyne
Croatia · Mifegyne
Ireland · Mifegyne
Iceland · Mifegyne
Italy · Mifegyne
Lithuania · Mifegyne
Luxembourg · Mifegyne
Latvia · Mifegyne
Norway · Mifegyne
Portugal · Mifegyne
Romania · Mifegyne
Sweden · Mifegyne, Mifepristone Nordic
Slovenia · Mifegyne

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/04529eaa-00cd-46bf-a6c0-e3dad02a5178
GET /v1/drugs/04529eaa-00cd-46bf-a6c0-e3dad02a5178?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h24206_smpc.pdf",
  "strength": null,
  "atc_label": "Mifepristone",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg128040",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL",
    "POVIDON K 30 (E 1201)",
    "SILICIUMDIOXIDE (E 551)"
  ],
  "substances": [
    "MIFEPRISTON"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h128040.pdf",
  "authorised_at": "2021/03/16",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "128040//24206",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about mifepristone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console